Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

FDMTFDMT
16 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in 4D MOLECULAR THERAPEUTICS IN

VIKING GLOBAL INVESTORS LP previously held 0 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$163.2M

Total Shares Change

-3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$10.83
0
2024-Q2
Unchanged
2.9M
0.0%
$61.6M0.2%$20.99
0
2024-Q1
Decreased
2.9M
-38.7%
$93.5M0.3%$31.86
0
2023-Q4
Unchanged
4.8M
0.0%
$97M0.4%$20.26
0
2023-Q3
Unchanged
4.8M
0.0%
$61M0.2%$12.73
0
2023-Q2
Increased
4.8M
+21.6%
$86.5M0.4%$17.73
43
2023-Q1
Unchanged
3.9M
0.0%
$67.7M0.3%$16.75
0
2022-Q4
Unchanged
3.9M
0.0%
$87.5M0.4%$22.21
0
2022-Q3
Unchanged
3.9M
0.0%
$31.7M0.1%$8.22
0
2022-Q2
Unchanged
3.9M
0.0%
$27.5M0.1%$7.27
0
2022-Q1
Unchanged
3.9M
0.0%
$59.5M0.2%$15.49
0
2021-Q4
Unchanged
3.9M
0.0%
$86.4M0.2%$21.87
0
2021-Q3
Unchanged
3.9M
0.0%
$106.2M0.3%$27.92
0
2021-Q2
Unchanged
3.9M
0.0%
$94.8M0.3%$23.50
0
2021-Q1
Unchanged
3.9M
0.0%
$170.8M0.5%$38.55
0
2020-Q4
New
3.9M
-
$163.2M0.4%$41.64
50

Other major holders of FDMT: RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used